Pulmonx Corporation (LUNG)

Pulmonx Corporation is a medical technology company focused on developing and marketing innovative therapies for patients with severe lung disease. The company's primary focus is on improving the lives of individuals suffering from chronic obstructive pulmonary disease (COPD), particularly those with emphysema. Pulmonx offers solutions designed to assess and treat advanced emphysema, helping physicians identify appropriate candidates for minimally invasive procedures. Their technology aims to reduce hyperinflation in the lungs, leading to improved breathing and quality of life for patients. By providing advanced diagnostic and therapeutic tools, Pulmonx plays a crucial role in advancing the treatment landscape for severe respiratory illnesses.